A341170 Stock Overview
Operates as a drug development company worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Future Medicine Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩2,470.00 |
| 52 Week High | ₩8,410.00 |
| 52 Week Low | ₩1,750.00 |
| Beta | 0 |
| 11 Month Change | -4.63% |
| 3 Month Change | -14.38% |
| 1 Year Change | -68.77% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -74.54% |
Recent News & Updates
Recent updates
Shareholder Returns
| A341170 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | -1.2% | -9.2% | -2.8% |
| 1Y | -68.8% | 8.0% | -3.4% |
Return vs Industry: A341170 underperformed the KR Pharmaceuticals industry which returned 8% over the past year.
Return vs Market: A341170 underperformed the KR Market which returned -3.4% over the past year.
Price Volatility
| A341170 volatility | |
|---|---|
| A341170 Average Weekly Movement | 11.7% |
| Pharmaceuticals Industry Average Movement | 5.5% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in KR Market | 11.5% |
| 10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A341170's share price has been volatile over the past 3 months compared to the KR market.
Volatility Over Time: A341170's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | n/a | Shin Jeong Lak | www.futuremedicine.co.kr |
Future Medicine Co., Ltd. operates as a drug development company worldwide. It develops drugs for use in the treatment of fibrosis and inflammation in non-alcoholic steatohepatitis, chronic kidney disease, glaucoma, and primary biliary cirrhosis; colorectal, prostate, and lung cancer; and COVID-19 and rheumatoid arthritis/atopy. The company was founded in 2015 and is based in Seongnam, South Korea.
Future Medicine Co., Ltd. Fundamentals Summary
| A341170 fundamental statistics | |
|---|---|
| Market cap | ₩22.91b |
| Earnings (TTM) | ₩0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs A341170 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A341170 income statement (TTM) | |
|---|---|
| Revenue | ₩0 |
| Cost of Revenue | ₩0 |
| Gross Profit | ₩0 |
| Other Expenses | ₩0 |
| Earnings | ₩0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did A341170 perform over the long term?
See historical performance and comparison